48
Participants
Start Date
June 27, 2007
Primary Completion Date
May 25, 2011
Study Completion Date
May 25, 2011
rituximab [MabThera/Rituxan]
375mg/m2 iv every 3 weeks
First line chemotherapy
As prescribed
National Institute of Oncology, A Dept of Internal Medicine, Budapest
Miskolci Semmelweis Korhaz; Ii Belgyogyaszat, Miskolc
University of Debrecen Medical and Health Science Center, Institute of Internal Medicine, Hematology, Debrecen
University of Szeged, II Dept of Internal Medicine, Szeged
Kaposi Mor Teaching Hospital, Dept of Internal Medicine/Hematology, Kaposvár
Zala Megyei Korhaz; Ii. Belgyogyaszat, Zalaegerszeg
Petz Aladar Megyei Korhaz; Hematologia, Győr
Hoffmann-La Roche
INDUSTRY